Image

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

Description

Primary Objective:

To compare overall percentage of days spent in an acute care setting over the 30-day period from time of the index emergency department (ED), referred to as Acute Cancer Care Center (ACCC), visit for patients who receive the emergency department-based GOC intervention and those who do not.

Secondary Objective:

To obtain data on rates of admission to the ICU, death in the hospital setting, symptom improvement for participants hospitalized, hospice referral, survival, and 30-day care costs for participants who receive the GOC intervention in the ACCC and those who do not.

Eligibility

Inclusion Criteria:

  1. Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment
  2. Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative treatment available.
  3. Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)
  4. Participant has the ability to speak and write in English
  5. Participant has the ability to provide consent OR is accompanied by a LAR able to provide consent

Exclusion Criteria:

  1. Participant is already enrolled in hospice
  2. Participant is comatose
  3. Participant has severe intellectual disability
  4. Participant has a history of dementia documented in the medical records
  5. Participant has baseline communication barriers such as aphasia or deafness
  6. Participant is new to MDACC, without established oncology care at our institution at time of ACCC arrival
  7. Participant is 18 years or older, currently cared for by pediatrics service
  8. Pregnant women
  9. Prisoners

Study details

Lung Cancer, Gastrointestinal Cancer

NCT06420206

M.D. Anderson Cancer Center

29 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.